CYP1A2

Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt.

Cytochroma P450 CYP1A2 (-atis, n.) (Numerus EC: 1.14.14.1) est haemoproteinum et pars gregis Cytochroma P450 ideo in metabolismo Coffeini (Coffeum, Thea, Cola, Mate, Paullinia cupana/Guaraná, energy drink) et oestrogenorum interest.

Expressio geni CYP1A2 brassicis et tabaco et medicamento Omeprazoli (inductores) aucta est.

Cuminum et Curcuma et Hypericum Perforatum et Malum paradisi et antibioticum Ciprofloxacini (inhibitores) haemoproteinum CYP1A2 inhibent.

Fieri potest ut functio aucta CYP1A2 periculo aucto cancri mammae praesit^[1]

Locus

Multa antidepressiva substratum cytochromatis 1A2 sunt. Inhibitores ut ciprofloxacinum (antibioticum) effectus substratorum augere possunt.

Substrati	Inhibitores^[4]	Inductores^[5]
Pharmaca relata ad CYP1A2^[2]^[3].
Substantiae antidepressivae Antidepressiva tricyclica Amitriptylinum Clomipraminum Imipraminum Antidepressiva tetracyclica Mirtazapinum^[6] Agomelatinum Antipsychotica Clozapinum Olanzapinum Haloperidolum Coffeinum Ropivacainum Theophyllinum Zolmitriptanum Melatoninum Tamoxifenum Erlotinibum Cyclobenzaprinum Oestradiolum Fluvoxaminum Mexiletinum Naproxenum Ondansetronum Phenacetinum Paracetamolum Propranololum Riluzolum Tacrinum Tizanidinum Verapamilum Varfarinum^[7] Zileutonum Naphthalinum ^[8]	Psychopharmaca Fluvoxaminum Perazinum Cimetidinum Antibiotica Ciprofloxacinum (forte) Norfloxacinum Isoniazidum Amiodaronum Enoxacinum Hypericum perforatum Interferonum Cuminum cyminum^[9] Aethinyl-oestradiolum	Carbamezepinum Phenytoinum Tabacum Omeprazolum Brassicarum diversae Brassica oleracea: Cauliculus Bruxellanus^[9] Var. botrytis^[9] Var. italica^[9] Lopanivirum-Ritonavirum Ritonavirum Modafinilum

↑ Hong CC, Tang BK, Rao V, Agarwal S, Martin L, Tritchler M, Yaffe M, Boyd NF (2004). Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study. Breast Cancer Res 6: 7, pp. 338–351 http://download.springer.com/static/pdf/139/art%253A10.1186%252Fbcr797.pdf?originUrl=https%3A%2F%2Ffanyv88.com%3A443%2Fhttp%2Fbreast-cancer-research.biomedcentral.com%2Farticle%2F10.1186%2Fbcr797&token2=exp=1482277547~acl=%2Fstatic%2Fpdf%2F139%2Fart%25253A10.1186%25252Fbcr797.pdf*~hmac=088fe1b55e95e49a9e798c6dbb6af0466e5327eec218fba5763fe045d52662ae^{[nexus deficit]}
↑ Cozza KL, Armstrong SC (2001). The Cytochrome P450 System. Drug Interaction Principles for Medical Practice. Washington, DC: American Psychiatric Publishing
↑ Preskorn SH (1996). Clinical Pharmacology of Selective Serotonin Reuptake Inhibitors. 1st ed.: Professional Communications, Inc.
↑ Inhibitor cum subtratorum effectibus fortioribus
↑ Inductor cum subtratorum effectibus minoribus
↑ Metabolismus CYP1A2 lentior quam CYP2D6
↑ Anglice: Warfarin, WARF = Wisconsin Alumni Research Foundation; -arin: ex Coumarin derivatur
↑ Cho T. M., Rose R. L., Hodgson E. (2006). "In vitro metabolism of naphthalene by human liver microsomal cytochrome P450 enzymes". Drug metabolism and disposition 34 (1): 176-83
↑ ^9.0 ^9.1 ^9.2 ^9.3 homines cum effectibus variis cytochromati CYP1A2 (Anglice)